FilingPulse

ANRO insider transaction filings

Alto Neuroscience, Inc. — 30 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-29. Screen ANRO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-05-294Miller Andrew Craig — DirectorGrant/award (A): 26,000 (derivative) @ $0EDGAR
2026-05-154Etkin Amit — PRESIDENT AND CEO, DirectorGift (G): 400,000 @ $0EDGAR
2026-05-144Manji Husseini — DirectorGrant/award (A): 10,958 (derivative) @ $0EDGAR
2026-05-144York Gwill — DirectorGrant/award (A): 10,958 (derivative) @ $0EDGAR
2026-05-144Cox Christopher Nixon — DirectorGrant/award (A): 10,958 (derivative) @ $0EDGAR
2026-05-144Sanchez Ramiro — DirectorGrant/award (A): 10,958 (derivative) @ $0EDGAR
2026-05-144Dreyfus Andrew — DirectorGrant/award (A): 10,958 (derivative) @ $0EDGAR
2026-03-034Smith Nicholas Conrad — CHIEF FINANCIAL OFFICER & CBOTax withholding (F): 2,806 @ $19.69EDGAR
2026-03-034Etkin Amit — PRESIDENT AND CEO, DirectorTax withholding (F): 6,227 @ $19.69EDGAR
2026-02-134Smith Nicholas Conrad — CHIEF FINANCIAL OFFICER & CBOGrant/award (A): 200,000 (derivative) @ $0EDGAR
2026-02-134Savitz Adam — CHIEF MEDICAL OFFICERGrant/award (A): 124,000 (derivative) @ $0EDGAR
2026-02-134Etkin Amit — PRESIDENT AND CEO, DirectorGrant/award (A): 306,000 (derivative) @ $0EDGAR
2026-02-134Hanley Jr. Michael Conick — CHIEF OPERATING OFFICERGrant/award (A): 131,000 (derivative) @ $0EDGAR
2026-01-064Manji Husseini — DirectorGrant/award (A): 4,228 (derivative) @ $11.82EDGAR
2026-01-064York Gwill — DirectorGrant/award (A): 5,243 (derivative) @ $11.82EDGAR
2026-01-064Cox Christopher Nixon — DirectorGrant/award (A): 7,189 (derivative) @ $11.82EDGAR
2026-01-064Sanchez Ramiro — DirectorGrant/award (A): 3,806 (derivative) @ $11.82EDGAR
2025-08-144Sanchez Ramiro — DirectorGrant/award (A): 30,574 (derivative) @ $0 · Grant/award (A): 3,928 (derivative) @ $2.21EDGAR
2025-07-084Savitz Adam — CHIEF MEDICAL OFFICERGrant/award (A): 22,481 (derivative) · Disposition to issuer (D): 22,481 (derivative) · Grant/award (A): 33,008 (derivative) · Disposition to issuer (D): 33,008 (derivative) · Grant/award (A): 123,645 (derivative) · Disposition to issuer (D): 123,645 (derivative) · +4 moreEDGAR
2025-07-084Etkin Amit — PRESIDENT AND CEO, DirectorGrant/award (A): 34,620 (derivative) · Disposition to issuer (D): 34,620 (derivative) · Grant/award (A): 247,290 (derivative) · Disposition to issuer (D): 247,290 (derivative) · Grant/award (A): 223,000 (derivative) · Disposition to issuer (D): 223,000 (derivative) · +2 moreEDGAR
2025-07-084Smith Nicholas Conrad — CHIEF FINANCIAL OFFICER & CBOGrant/award (A): 44,962 (derivative) · Disposition to issuer (D): 44,962 (derivative) · Grant/award (A): 33,833 (derivative) · Disposition to issuer (D): 33,833 (derivative) · Grant/award (A): 202,329 (derivative) · Disposition to issuer (D): 202,329 (derivative) · +4 moreEDGAR
2025-07-084Hanley Jr. Michael Conick — CHIEF OPERATING OFFICERGrant/award (A): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Grant/award (A): 188,000 (derivative) · Disposition to issuer (D): 188,000 (derivative) · Grant/award (A): 125,000 (derivative) · Disposition to issuer (D): 125,000 (derivative)EDGAR
2025-05-154Manji Husseini — DirectorGrant/award (A): 15,287 (derivative) @ $0EDGAR
2025-05-154Cox Christopher Nixon — DirectorGrant/award (A): 15,287 (derivative) @ $0EDGAR
2025-05-154York Gwill — DirectorGrant/award (A): 15,287 (derivative) @ $0EDGAR
2025-05-154Dreyfus Andrew — DirectorGrant/award (A): 15,287 (derivative) @ $0EDGAR
2025-02-074Smith Nicholas Conrad — CHIEF FINANCIAL OFFICER & CBOGrant/award (A): 135,000 (derivative) @ $0EDGAR
2025-02-074Savitz Adam — CHIEF MEDICAL OFFICERGrant/award (A): 76,000 (derivative) @ $0EDGAR
2025-02-074Etkin Amit — PRESIDENT AND CEO, DirectorGrant/award (A): 215,000 (derivative) @ $0EDGAR
2025-02-074Hanley Jr. Michael Conick — CHIEF OPERATING OFFICERGrant/award (A): 125,000 (derivative) @ $0EDGAR

Recent 8-K events — Alto Neuroscience, Inc.

FiledFormItems reportedSource
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-148-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-138-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events		EDGAR
2026-05-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-168-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ANRO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →